Anti-acetylated huntingtin antibodies and uses therof
AssigneeThe General Hospital Corporation
InventorsDimitri Krainc, Hyunkyung Jeong, Florian Then
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe General Hospital Corporation
InventorsDimitri Krainc, Hyunkyung Jeong, Florian Then
Estimating the term…
This invention includes, in part, methods of preparing acetylated Huntingtin (Htt) polypeptides, acetylated Htt polypeptide antigens, and antibodies that specifically recognize acetylated epitopes on Htt polypeptides. The invention also relates, in part, to the preparation and use of antibodies that specifically recognize and bind to acetylated epitopes on acetylated Htt polypeptides when an acetylated residue on the Htt polypeptide is a lysine that corresponds to K444 residue of full-length, wild-type Htt polypeptide. In some aspects, the invention includes hybridoma cell lines that produce antibodies that specifically bind acetylated Htt polypeptide and also includes antibodies and antigen-binding fragments thereof produced using polypeptides of the invention.
An isolated monoclonal antibody or antigen-binding fragment thereof that binds specifically to an epitope of acetylated human Htt polypeptide, but does not bind specifically to non-acetylated human Htt polypeptide, wherein the epitope comprises lysine K444 of human Htt polypeptide.
Dependencies are inferred from the claim text.